Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Hassan H, Anwer F, Javaid A, Hashmi H. Progress in research: Daratumumab improves treatment outcomes of patients with AL amyloidosis. Crit Rev Oncol Hematol 2021;165:103435. [PMID: 34343658 DOI: 10.1016/j.critrevonc.2021.103435] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2020] [Revised: 07/13/2021] [Accepted: 07/28/2021] [Indexed: 12/19/2022] Open

For:	Hassan H, Anwer F, Javaid A, Hashmi H. Progress in research: Daratumumab improves treatment outcomes of patients with AL amyloidosis. Crit Rev Oncol Hematol 2021;165:103435. [PMID: 34343658 DOI: 10.1016/j.critrevonc.2021.103435] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2020] [Revised: 07/13/2021] [Accepted: 07/28/2021] [Indexed: 12/19/2022] Open

Number

Cited by Other Article(s)

Davis JA, Hashmi H. ANDROMEDA: Dara-VCd for Newly Diagnosed AL Amyloidosis: The Next Galaxy or a New Standard of Care? Expert Opin Biol Ther 2022;22:445-447. [PMID: 35084284 DOI: 10.1080/14712598.2022.2035357] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]